{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:10:07Z","timestamp":1744348207208,"version":"3.40.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.imlet.2025.107004","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T06:10:16Z","timestamp":1743228616000},"page":"107004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-2009","authenticated-orcid":false,"given":"Nicole Hartwig","family":"Trier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8314-5952","authenticated-orcid":false,"given":"Nadia","family":"Zivlaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-3851","authenticated-orcid":false,"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-9077","authenticated-orcid":false,"given":"Erik","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimantas","family":"Slibinskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaldas","family":"Ciplys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette Lautrup","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5948-4156","authenticated-orcid":false,"given":"Gunnar","family":"Houen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107004_bib0001","article-title":"Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies","volume":"14","author":"Achiron","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.imlet.2025.107004_bib0002","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10461-008-9358-4","article-title":"Population levels of psychological stress, herpesvirus reactivation and HIV","volume":"14","author":"Aiello","year":"2010","journal-title":"AIDS Behav."},{"key":"10.1016\/j.imlet.2025.107004_bib0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/jiac020","article-title":"Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization","volume":"226","author":"Alanio","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0004","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid2206.160010","article-title":"Antibody response and disease severity in healthcare worker MERS survivors","volume":"22","author":"Alshukairi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41541-021-00396-3","article-title":"Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination","volume":"6","author":"Assis","year":"2021","journal-title":"NPJ. Vaccines."},{"key":"10.1016\/j.imlet.2025.107004_bib0006","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.7150\/jca.37282","article-title":"Epstein Barr virus associated lymphomas and epithelia cancers in humans","volume":"11","author":"Ayee","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.imlet.2025.107004_bib0007","article-title":"Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020","volume":"3","author":"Ayoub","year":"2021","journal-title":"Glob. Epidemiol."},{"key":"10.1016\/j.imlet.2025.107004_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199157","article-title":"Incidence of Esptein-Barr virus reactivation is elevated in COVID-19 patients","volume":"334","author":"Bernal","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.imlet.2025.107004_bib0009","first-page":"296","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.imlet.2025.107004_bib0010","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jamaneurol.2021.3599","article-title":"Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab","volume":"78","author":"Brill","year":"2021","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.imlet.2025.107004_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.imlet.2025.107004_bib0012","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/2165079920914947","article-title":"Novel coronavirus (COVID-19): what you need to know","volume":"68","author":"Carver","year":"2020","journal-title":"Workplace Health Saf."},{"key":"10.1016\/j.imlet.2025.107004_bib0013","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2025.107004_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41392-020-00301-9","article-title":"Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19","volume":"5","author":"Chen","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.imlet.2025.107004_bib0015","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2025.107004_bib0016","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"Dewolf","year":"2022","journal-title":"Immunity."},{"key":"10.1016\/j.imlet.2025.107004_bib0017","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jamaneurol.2021.3609","article-title":"Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 Vaccines in patients with multiple sclerosis","volume":"78","author":"Disanto","year":"2021","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.imlet.2025.107004_bib0018","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1111\/cas.15440","article-title":"Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma","volume":"113","author":"Dochi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imlet.2025.107004_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101674","article-title":"Lymphomas associated with Epstein-Barr virus infection in 2020: results from a large, unselected case series in France 2022","volume":"54","author":"Donzel","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.imlet.2025.107004_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","author":"Draborg","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.DMIH2-0026-2016","article-title":"Overview of infections in the immunocompromised host","volume":"4","author":"Dropulic","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.imlet.2025.107004_bib0022","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","article-title":"Chemistry and biology of SARS-CoV-2","volume":"6","author":"D\u00f6mling","year":"2020","journal-title":"Chem."},{"key":"10.1016\/j.imlet.2025.107004_bib0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0024","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of Long COVID prevalence and its relationship to Epstein-Barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens."},{"key":"10.1016\/j.imlet.2025.107004_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ped.12314","article-title":"Current research on chronic active Epstein-Barr virus infection in Japan","volume":"56","author":"Fujiwara","year":"2014","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.imlet.2025.107004_bib0026","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-virology-110615-042422","article-title":"Human cytomegalovirus latency: approaching the gordian knot","volume":"3","author":"Goodrum","year":"2016","journal-title":"Annu Rev. Virol."},{"key":"10.1016\/j.imlet.2025.107004_bib0027","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.imlet.2025.107004_bib0028","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms23031716","article-title":"SARS-CoV-2-specific immune response and the pathogenesis of COVID-19","volume":"23","author":"Gusev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107004_bib0029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2023.02.003","article-title":"Antibodies to expanded virus antigen panels show elevated diagnostic sensitivities in multiple sclerosis and optic neuritis","volume":"254","author":"G\u00e5sland","year":"2023","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2025.107004_bib0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/crj.12433","article-title":"Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit","volume":"11","author":"He","year":"2017","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.imlet.2025.107004_bib0031","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-022-07262-0","article-title":"Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies","volume":"22","author":"Herrera-Esposito","year":"2022","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587078","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"11","author":"Houen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0034","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2025.107004_bib0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0036","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","article-title":"Epstein-Barr virus reactivation and therapeutic inhibitors","volume":"72","author":"Kerr","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.imlet.2025.107004_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117230","article-title":"Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic","volume":"420","author":"Kovvuru","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2025.107004_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577868","article-title":"Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis","volume":"367","author":"Kyllesbech","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.937583","article-title":"Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: results from a cohort study of 32,116 outpatients in Germany","volume":"13","author":"Loosen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107004_bib0041","first-page":"56","article-title":"Clinical and laboratory differences between Epstein-Barr and cytomegalovirus infectious mononucleosis in children","volume":"144","author":"Medovi\u0107","year":"2016","journal-title":"Serbian Arch. Med."},{"key":"10.1016\/j.imlet.2025.107004_bib0042","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1038\/s41598-021-88356-8","article-title":"Analysis of IgM, IgA, and IgG isotype antibodies directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19","volume":"11","author":"Meinberger","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107004_bib0043","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41467-022-29307-3","article-title":"Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank","volume":"13","author":"Mentzer","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2025.107004_bib0044","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2025.107004_bib0045","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jinf.2020.04.026","article-title":"How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review","volume":"81","author":"Minotti","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.imlet.2025.107004_bib0046","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/v13122344","article-title":"Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses."},{"key":"10.1016\/j.imlet.2025.107004_bib0047","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3201\/eid2510.190051","article-title":"Sensitive and specific detection of low-level antibody responses in mild middle east respiratory syndrome coronavirus infections","volume":"25","author":"Okba","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0048","doi-asserted-by":"crossref","first-page":"e1101","DOI":"10.1212\/NXI.0000000000001101","article-title":"Impact of COVID-19 in immunosuppressed children with neuroimmunologic disorders","volume":"9","author":"Oliv\u00e9-Cirera","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.imlet.2025.107004_bib0049","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection","volume":"89","author":"Palser","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2025.107004_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081881","article-title":"Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study","volume":"8","author":"Pembrey","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.imlet.2025.107004_bib0051","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(20)30578-8","article-title":"MERS-CoV in Africa-an enigma with relevance to COVID-19","volume":"21","author":"Perlman","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0052","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/cid\/ciab237","article-title":"High infection secondary attack rates of severe acute respiratory syndrome coronavirus 2 in dutch households revealed by dense sampling","volume":"74","author":"Reukers","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imlet.2025.107004_bib0053","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"2","author":"Rostgaard","year":"2019","journal-title":"PLoS. One"},{"key":"10.1016\/j.imlet.2025.107004_bib0054","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.chom.2021.06.009","article-title":"Antibody and B cell responses to SARS-CoV-2 infection and vaccination","volume":"29","author":"R\u00f6ltgen","year":"2021","journal-title":"Cell Host. Microbe"},{"key":"10.1016\/j.imlet.2025.107004_bib0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/pathogens11080831","article-title":"CD4+ cytotoxic T cells involved in the development of EBV-associated diseases","volume":"11","author":"Ruiz-Palos","year":"2022","journal-title":"Pathogens."},{"key":"10.1016\/j.imlet.2025.107004_bib0056","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/biom11091380","article-title":"Stress-induced Epstein-Barr virus reactivation","volume":"11","author":"Sausen","year":"2021","journal-title":"Biomolecules."},{"key":"10.1016\/j.imlet.2025.107004_bib0057","first-page":"707","article-title":"Epstein-Barr virus in healthy individuals from Portugal","volume":"24","author":"Sousa","year":"2011","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.imlet.2025.107004_bib0058","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1469-0691.2007.01781.x","article-title":"Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system","volume":"13","author":"Steininger","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.imlet.2025.107004_bib0059","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s43856-022-00178-5","article-title":"Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients","volume":"2","author":"Svanberg","year":"2022","journal-title":"Commun. Med. (Lond)"},{"key":"10.1016\/j.imlet.2025.107004_bib0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/23744235.2022.2070273","article-title":"Cytomegalovirus coinfection in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review of reported cases","volume":"54","author":"Taherifard","year":"2022","journal-title":"Infect Dis"},{"key":"10.1016\/j.imlet.2025.107004_bib0061","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41598-018-22058-6","article-title":"Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis","volume":"8","author":"Trier","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107004_bib0062","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713609","article-title":"Antibody cross-reactivity in auto-immune diseases","volume":"24","author":"Trier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107004_bib0063","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/pathogens1020156","article-title":"Epstein-Barr virus sequence variation variation-biology and disease","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens."},{"key":"10.1016\/j.imlet.2025.107004_bib0064","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China Novel Coronavirus investigating and Research Team. 2020. A novel coronavirus from patients with pneumonia in China","volume":"382","author":"Zhu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107004_bib0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/v14020370","article-title":"Antibody response to SARS-CoV-2 infection and vaccination in COVID-19-na\u00efve and experienced individuals","volume":"14","author":"Uprichard","year":"2022","journal-title":"Viruses."},{"year":"2023","series-title":"Coinfection With SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19","author":"Ura","key":"10.1016\/j.imlet.2025.107004_bib0066"},{"key":"10.1016\/j.imlet.2025.107004_bib0067","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2022017650","article-title":"HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD","volume":"141","author":"Vietzen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2025.107004_bib0068","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOH.0b013e32834daa08","article-title":"Current diagnosis and management of infectious mononucleosis","volume":"19","author":"Vouloumanou","year":"2012","journal-title":"CurrO pin Hematol"},{"key":"10.1016\/j.imlet.2025.107004_bib0069","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/v15020400","article-title":"Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID","volume":"15","author":"Vojdani","year":"2023","journal-title":"Viruses."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:30:51Z","timestamp":1744345851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"alternative-id":["S0165247825000367"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107004"}}